Sandar Aye

Articles

Article: PHARMACOECONOMICS (AUCKLAND). 2024;:1-17
Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study
Aye S; Frisell O; Zetterberg H; Skillback TB; Kern S; Eriksdotter M; Aho E; Xia X; Winblad B; Wimo A; Joensson L
Article: VALUE IN HEALTH. 2024;26(12):S419
IPECAD MODELING WORKSHOP 2023 CROSS COMPARISON CHALLENGE ON COST-EFFECTIVENESS MODELS IN ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
Handels R; Herring W; Kamgar F; Gustavsson A; Skoldunger A; Wimo A; Tate A; Winblad B; Stellick CB; Bruck C; Green C; de Kok I; Hlavka J; Mar J; Urbich M; Soto-Gordoa M; Pemberton-Ross P; Aye S; Jonsson L
Article: THE JOURNAL OF PREVENTION OF ALZHEIMER'S DISEASE. 2024;11(4):928-942
Optimising Alzheimer's Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment
Aye S; Handels R; Winblad B; Jonsson L
Article: ALZHEIMER'S RESEARCH AND THERAPY. 2023;15(1):200
Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis
Aye S; Bouteloup V; Tate A; Wimo A; Handels R; Jean D; Winblad B; Joensson L
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2023;15(1):e12422
Effect of mortality in cost-effectiveness modeling of disease-modifying treatment for Alzheimer's disease
Aye S; Jonsson L; Gustavsson A; Tate A; Ptacek SG; Eriksdotter M

Conference publication: VALUE IN HEALTH. 2023;26(12):s1
P3 Open-Source Model Framework for Health-Economic Evaluation of Early Treatment in Alzheimer's Disease
Handels R; Wimo A; Skoldunger A; Tate A; Winblad B; Silvertand D; Nguyen L; Jönsson L; Grimm S; Aye S; Herring W
Conference publication: VALUE IN HEALTH. 2022;25(12):S483
EFFECT OF MORTALITY ON COST-EFFECTIVENESS MODELING OF DISEASE-MODIFYING TREATMENT FOR ALZHEIMER'S DISEASE
Aye S; Jonsson L